Search

Search Constraints

You searched for: Author/Creator Ciuffreda, Loreta Pia

Search Results

1. Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium. (July 2020)

2. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi‐targeted kinase inhibitors in pimasertib‐resistant human lung and colorectal cancer cells. Issue 9 (29th May 2013)

3. Effects of ranolazine in a model of doxorubicin‐induced left ventricle diastolic dysfunction. (16th May 2017)

4. Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction. (15th August 2016)

5. Lung Mesenchymal Stem Cells Ameliorate Elastase-Induced Damage in an Animal Model of Emphysema. (14th March 2018)

6. SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy. (15th February 2016)

7. SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy. (15th February 2016)

8. SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells. (15th June 2015)

9. SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells. (15th June 2015)

10. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction. (21st March 2017)